Bavarian Nordic appoints former Sanofi, AstraZeneca and Pfizer executive Tarja Stenvall as CEO
read at Endpoints ↗Neutral
Bavarian Nordic announced that Tarja Stenvall will become its president and chief executive, succeeding Paul Chaplin.
Stenvall brings decades of experience from senior roles at Sanofi, AstraZeneca and Pfizer, where she oversaw a range of development programs.
She is slated to assume the role on October 15, and she has indicated that strengthening the company’s vaccine pipeline will be a top priority.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Bavarian Nordic names Tarja Stenvall as new CEO”
read at Endpoints ↗86 words · retrieved 1h ago
comments(0)
5-min edit window · permanent after that